RPRX Insider Trading
Insider Ownership Percentage: 18.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Royalty Pharma Share Price & Price History
Current Price: $31.37
Price Change: ▼ Price Decrease of -0.28 (-0.88%)
As of 03/28/2025 05:00 PM ET
Royalty Pharma Insider Trading History
Royalty Pharma Institutional Trading History
Data available starting January 2016
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Read More on Royalty Pharma
Today's Range
Now: $31.37
52 Week Range
Now: $31.37
Volume
4,077,104 shs
Average Volume
3,103,202 shs
Market Capitalization
$18.08 billion
P/E Ratio
21.63
Dividend Yield
2.78%
Beta
0.47
Who are the company insiders with the largest holdings of Royalty Pharma?
Who are the major institutional investors of Royalty Pharma?
Which major investors are selling Royalty Pharma stock?
During the last quarter, RPRX stock was sold by these institutional investors:
- Baillie Gifford & Co.
- Janus Henderson Group PLC
- FMR LLC
- Amundi
- ADAR1 Capital Management LLC
- Franklin Resources Inc.
- Arrowstreet Capital Limited Partnership
- Nordea Investment Management AB
Which major investors are buying Royalty Pharma stock?
During the last quarter, RPRX stock was acquired by institutional investors including:
- Adage Capital Partners GP L.L.C.
- Norges Bank
- BNP Paribas Financial Markets
- AQR Capital Management LLC
- Swedbank AB
- Bank of America Corp DE
- Deutsche Bank AG
- Patient Capital Management LLC